Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 ...
Philips (NYSE: PHG) announced that it agreed to acquire SpectraWave, a developer of Enhanced Vascular Imaging (EVI) for ...
Please provide your email address to receive an email when new articles are posted on . Subclinical, obstructive coronary atherosclerosis was associated with an elevated risk for myocardial infarction ...
In a recent study published in the journal JACC Advances, researchers in the United States examined the presence of coronary atherosclerosis using coronary computed tomography angiography (CCTA) in ...
Abnormal retinal microvasculature on ophthalmic OCT angiography was associated with subclinical coronary atherosclerosis on coronary CT angiography in a cohort study. Retinal indicators observed on ...
Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 100 studies assessing over 365,000 patients. Proven in real-world ...
Philips and SpectraWAVE logos. December 15, 2025. Acquisition of SpectraWAVE’s next-generation technologies including ...
In patients with diabetes and multivessel coronary artery disease undergoing percutaneous coronary intervention, ticagrelor ...
Unfortunately, we hear stories like this far too often: people who seem like the healthiest humans on the planet, only to ...
SpectraWAVE makes technologies to help diagnose and guide treatment decisions for coronary artery disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback